Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Difluprednate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 known ✓ | P04150 | 7/20 | 0.60 |
| ▸ | LMNA | P02545 | 9/20 | 0.66 |
| ▸ | HIF1A | Q16665 | 7/20 | 0.66 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.66 |
| ▸ | PGR | P06401 | 7/20 | 0.60 |
| ▸ | AR | P10275 | 3/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | ABCB11 | O95342 | 2/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | HTR1A | P08908 | 1/20 | 0.52 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.52 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluocinonide SCHEMBL616754 | 0.90 | NR3C1 (0.74) | LMNAHIF1ANPSR1NR3C1PGR | |
| Fluocinonide SCHEMBL15568196 | 0.87 | HIF1A (0.58) | LMNAHIF1ANPSR1NR3C1PGR | |
| Fluocinolone Acetonide SCHEMBL8450831 | 0.86 | NR3C1 (0.77) | LMNAHIF1ANPSR1NR3C1PGR | |
| Amcinonide SCHEMBL22684943 | 0.85 | NR3C1 (0.64) | LMNAHIF1ANPSR1NR3C1PGR | |
| Difluprednate SCHEMBL28142821 | 0.85 | HIF1A (0.71) | LMNAHIF1ANPSR1NR3C1PGR | |
| Difluprednate SCHEMBL13724380 | 0.85 | HIF1A (0.71) | LMNAHIF1ANPSR1NR3C1PGR | |
| Prednicarbate SCHEMBL6470591 | 0.85 | NR3C1 (0.57) | LMNAHIF1ANPSR1NR3C1PGR | |
| Fluocinolone Acetonide SCHEMBL15568127 | 0.83 | HIF1A (0.57) | LMNAHIF1ANPSR1NR3C1PGR | |
| Betamethasone Valerate SCHEMBL8449742 | 0.83 | NR3C1 (0.64) | LMNAHIF1ANR3C1PGRAR | |
| Difluprednate SCHEMBL23343379 | 0.81 | HIF1A (1.00) | LMNAHIF1ANPSR1NR3C1PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9216106-B2 | Device and method for the delivery of drugs for the treatment of posterior segment disease | DIRECTCONTACT LLC (US) | 2015-12-22 | — | — | US | disclosed |
| US-20080318843-A1 | Device and Method for the Delivery of Drugs for the Treatment of Posterior Segment Disease | DIRECTCONTACT LLC (US) | 2008-12-25 | — | — | US | disclosed |